SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-056954
Filing Date
2024-05-09
Accepted
2024-05-09 16:10:48
Documents
73
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q svra-20240331.htm   iXBRL 10-Q 1149402
2 EX-10.1 svra-ex10_1.htm EX-10.1 508499
3 EX-31.1 svra-ex31_1.htm EX-31.1 14389
4 EX-31.2 svra-ex31_2.htm EX-31.2 14390
5 EX-32.1 svra-ex32_1.htm EX-32.1 10938
6 GRAPHIC img165634578_0.jpg GRAPHIC 29617
7 GRAPHIC img165634578_1.jpg GRAPHIC 9189
8 GRAPHIC img199011388_0.jpg GRAPHIC 3968
  Complete submission text file 0000950170-24-056954.txt   6736337

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT svra-20240331.xsd EX-101.SCH 1024368
77 EXTRACTED XBRL INSTANCE DOCUMENT svra-20240331_htm.xml XML 1013237
Mailing Address 6836 BEE CAVE ROAD BUILDING 3, SUITE 201 AUSTIN TX 78746
Business Address 6836 BEE CAVE ROAD BUILDING 3, SUITE 201 AUSTIN TX 78746 51285113796
Savara Inc (Filer) CIK: 0001160308 (see all company filings)

IRS No.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32157 | Film No.: 24930674
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)